Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protopic for stable facial or neck vitiligo
ChiCTR-ONRC-10000797Phase 4Completed
- Sponsor
- Chinese Dermatologist Association
- Start
- Jan 2010
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Envarsus XR in Vitiligo, sponsored by Chinese Dermatologist Association. Primary endpoints: Level of pigment restoration and Area of pigment restoration. Started Jan 2010; status: completed.
02
Drugs
Envarsus XR
03
Conditions
Vitiligo
Beyond the preview
Go deeper on ChiCTR-ONRC-10000797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-10000797.